돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 521생성일: 2026년 10월 23일

tert-Butyl piperazine-1-carboxylate → N-(4-methoxy-3-piperazin-1-yl-phenyl)-acetamide

https://huagongshe.com/ko/reaction/521

반응식

참여 물질

역할이름HCID투입량
반응물tert-Butyl piperazine-1-carboxylateHCID 143452—
반응물N-(3-bromo-4-methoxyphenyl)acetamideHCID 244158—
시약Sodium t-butoxideHCID 23676156—
촉매Palladium (II) acetateHCID 4144353—
촉매2-Dicyclohexylphosphino-2',6'-diisopropoxybiphenylHCID 16217985—
용매TolueneHCID 1140—
생성물N-(4-methoxy-3-piperazin-1-yl-phenyl)-acetamideHCID 8248061450.91%

반응 조건

온도100 °C

반응 단계

A solution of N-(3-bromo-4-methoxyphenyl)acetamide (0.5 g, 2.05 mmol) dissolved in toluene (5 mL) was treated with tert-butyl piperazine-1-carboxylate (0.382 g, 2.05 mmol), diacetoxypalladium (0.046 g, 0.20 mmol), dicyclohexyl(2',6'-diisopropoxybiphenyl-2-yl)phosphine (0.191 g, 0.41 mmol) and sodium 2-methylpropan-2-olate (0.433 g, 4.51 mmol) in a sealed tube. The resulting mixture was degassed and stirred at 100 °C for 8 hours in a microwave. The mixture was pre-absorbed onto silica. The crude product was purified by flash silica chromatography, elution 50% ethyl acetate in Heptane. Pure fractions were evaporated to dryness to afford intermediate. The intermediate was dissolved in 4M HCl in dioxane (10mL) and stirred at RT overnight. The mixture was evaporated to give N-(4-methoxy-3-(piperazin-1-yl)phenyl)acetamide (0.260 g, 50.9 %) as a tan solid.

출처 및 근거

출처 데이터셋750 AstraZeneca ELN dataset
ORD IDord-d3fce1c8e3204b57a80e5c0d53c5c1f7
출처 메모750 AstraZeneca ELN dataset